Try our Advanced Search for more refined results

June 30, 2017

Biogen International GMBH et al v. Mylan Pharmaceuticals Inc.

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. June 18, 2020

    Mylan Gets Biogen MS Drug Patent Invalidated In W.Va. Court

    A West Virginia federal judge on Thursday invalidated several claims of a Biogen patent covering its blockbuster multiple sclerosis drug Tecfidera after finding the company wrongly worked a new invention into an old patent application.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login